in any case , since most of the powerful gastric secretory inhibitors produce carcinoid tumours in rats , and carcinoid tumours of the human stomach are rare and largely benign , there would be no risk even if the drugs did produce proliferative abnormalities of the human stomach .
C0038351
gastric
C0349529
carcinoid